Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trinity Biotech (TRIB) Cash & Equivalents (2016 - 2025)

Trinity Biotech's Cash & Equivalents history spans 17 years, with the latest figure at $5.1 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 0.56% to $5.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.1 million, a 0.56% decrease, with the full-year FY2025 number at $5.1 million, down 0.56% from a year prior.
  • Cash & Equivalents hit $5.1 million in Q4 2025 for Trinity Biotech, up from $1.5 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for TRIB hit a ceiling of $28.6 million in Q2 2021 and a floor of $1.5 million in Q2 2025.
  • Historically, Cash & Equivalents has averaged $14.5 million across 5 years, with a median of $7.3 million in 2022.
  • Biggest five-year swings in Cash & Equivalents: surged 106.33% in 2021 and later crashed 74.65% in 2022.
  • Tracing TRIB's Cash & Equivalents over 5 years: stood at $25.9 million in 2021, then tumbled by 74.61% to $6.6 million in 2022, then tumbled by 43.89% to $3.7 million in 2023, then skyrocketed by 39.99% to $5.2 million in 2024, then fell by 0.56% to $5.1 million in 2025.
  • Business Quant data shows Cash & Equivalents for TRIB at $5.1 million in Q4 2025, $1.5 million in Q2 2025, and $5.2 million in Q4 2024.